Washington Trust’s Globus Medical GMED Stock Holding History

Washington Trust’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$71.5K	–	863
2024 Q3	$71.5K	Hold	1,000	–	–	﹤0.01%	396
2024 Q2	$68.5K	Hold	1,000	–	–	﹤0.01%	398
2024 Q1	$53.6K	Hold	1,000	–	–	﹤0.01%	446
2023 Q4	$53.3K	Hold	1,000	–	–	﹤0.01%	419
2023 Q3	$49.6K	Hold	1,000	–	–	﹤0.01%	395
2023 Q2	$59.5K	Hold	1,000	–	–	﹤0.01%	391
2023 Q1	$56.6K	Hold	1,000	–	–	﹤0.01%	398
2022 Q4	$74.3K	Hold	1,000	–	–	﹤0.01%	348
2022 Q3	$60K	Hold	1,000	–	–	﹤0.01%	359
2022 Q2	$56K	Hold	1,000	–	–	﹤0.01%	383
2022 Q1	$74K	Buy	+1,000	New	+$69.5K	﹤0.01%	370
2021 Q4	–	Sell	-150,502	Closed	-$11.5M	–	994
2021 Q3	$11.5M	Buy	150,502 +1,304	+0.9%	+$105K	0.33%	95
2021 Q2	$11.6M	Buy	149,198 +64,875	+77%	+$4.61M	0.33%	93
2021 Q1	$5.2M	Buy	84,323 +8,923	+12%	+$565K	0.16%	125
2020 Q4	$4.92M	Buy	75,400 +9,590	+15%	+$551K	0.16%	122
2020 Q3	$3.26M	Buy	65,810 +32,045	+95%	+$1.65M	0.12%	128
2020 Q2	$1.61M	Buy	+33,765	New	+$1.63M	0.07%	140

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Washington Trust's GMED Position: Q4 2024 in Review

Washington Trust sold out of Globus Medical (GMED) in Q4 2024, closing a stake of 1,000 shares — an estimated $71.5K sold.

Washington Trust first reported a position in GMED in Q2 2020 and held it in 17 quarters. The position peaked at $11.6M in Q2 2021. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

Washington Trust reported no remaining Globus Medical position as of Q4 2024 after selling out during the quarter.
Washington Trust sold 1,000 Globus Medical shares in Q4 2024, an estimated $71.5K.
Washington Trust first reported a position in Globus Medical in Q2 2020 and held it in 17 quarters.
Washington Trust's Globus Medical position peaked at $11.6M in Q2 2021.
500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on Washington Trust's 13F filing for Q4 2024, filed 30 Jan 2025.